![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Five Years of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Infection Is Associated with Sustained Viral Suppression and Significant Regression of Fibrosis and Cirrhosis
|
|
|
Reported by Jules Levin
22nd Congress of the Asian Pacific Association for the Study of the Liver (APASL) Feb 16-19, 2012;
Taipei, Taiwan
E Gane1, N Tsai2, F Weilert3, M Buti4, IM Jacobson5,
MK Washington6, BN Bekele7, JD Bornstein7, JF Flaherty7,
JG McHutchison7, P Marcellin8
1Auckland City Hospital, Auckland, New Zealand; 2University of Hawaii at Manoa, Honolulu, HI, USA;
3Waikato Hospital, Hamilton, New Zealand; 4Hospital General Universitari Vall d'Hebron and Ciberehd, Barcelona, Spain;
5Medical College of Cornell University, New York, NY; USA; 6Vanderbilt University, Nashville, TN, USA;
7Gilead Sciences Inc., Foster City, CA, USA; 8Hopital Beaujon, Clichy, France
![APASL1.gif](../images/022712/022712-9/APASL1.gif)
![APASL2.gif](../images/022712/022712-9/APASL2.gif)
![APASL3.gif](../images/022712/022712-9/APASL3.gif)
![APASL4.gif](../images/022712/022712-9/APASL4.gif)
![APASL5.gif](../images/022712/022712-9/APASL5.gif)
![APASL6.gif](../images/022712/022712-9/APASL6.gif)
![APASL7.gif](../images/022712/022712-9/APASL7.gif)
![APASL8.gif](../images/022712/022712-9/APASL8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|